Insulin-Like Growth Factors Market to Grow at a CAGR of Over 11.8% from 2023 to 2031, reveals Growth Plus Reports

Newark, New Castle, USA, May 23, 2023 (GLOBE NEWSWIRE) — The market analysis of the global insulin-like growth factors market was conducted by Growth Plus Reports in 2022. The market is expected to hit a revenue CAGR of 11.8% by 2031.

Analysis of the global market for insulin-like growth factors indicates that during the forecast period, revenue share is likely to increase significantly. Hormones called insulin-like growth factors (IGFs) are essential for growth and development, especially in childhood and adolescence. 

Key Takeaways: 

• The global market for insulin-like growth factors is significantly fueled by the increasing prevalence of diabetes globally.
• According to the International Diabetes Federation (IDF), 578 million people worldwide (aged 20 to 79) are expected to have diabetes by 2030, up from an estimated 463 million in 2019.
• Estimates say around 10.5% of Americans and 9.6% of the Canadian population are affected with diabetes. 

Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/insulinlike-growth-factors-market/9034

                               Insulin-Like Growth Factors Market Scope

Competitive Landscape

A list of the companies operating in the global market for insulin-like growth factors includes: 

• Boehringer Ingelheim GmbH
• Genervon Biopharmaceuticals LLC
• Ascendis Pharma
• Regulaxis SAS 
• MedImmune LLC

Market Drivers and Restraints: 

The global insulin-like growth factors market revenue is driven by the increasing prevalence of growth disorders, and ongoing research and development efforts focused on understanding the mechanisms of IGFs and their potential therapeutic applications can drive innovation and the development of new IGF-based products. 

However, due to the pricing of IGF products and the availability of reimbursement, the insulin-like growth factors market revenue growth is expected to be restrained. 

Market Segmentation: 

• Based on type, the global insulin-like growth factors market is segmented into somatomedin C, mechano-growth factor, and IGF1. 
• Based on end users, the global insulin-like growth factors market is segmented into hospitals and medical centers. 

Segmentation By Type

Based on types, the mechano-growth factors segment dominates the global insulin-like growth factors market with the most significant revenue share. This large share of revenue is attributed to the promotion of the production of muscle protein. Furthermore, MGF can encourage cell proliferation, differentiation, and invasion due to its potent mitogenic effect. It is involved in tissue regeneration, wound healing, and muscle and organ development.

Regional Growth Dynamics

Based on the region, North America, with the largest revenue share, dominates the global insulin-like growth factors market. This large revenue share is attributed to the advanced healthcare systems, many endocrine issues, and a big focus on research and development are all present in North America. Diabetes is a significant health issue in North America due to the high prevalence of the condition.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/insulin-like-growth-factors-market/9034

Report Coverage 

Growth Plus Reports carried out extensive market research on the insulin-like growth factors market globally. We examined the fundamental market characteristics, significant investment opportunities, regional growth patterns, ten-year revenue estimates, competing market players, and mergers and acquisitions.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL INSULIN-LIKE GROWTH FACTORS MARKET – ANALYSIS & FORECAST, BY TYPE
   1. Somatomedin C
   2. Mechano Growth Factor
   3. IGF1
6. GLOBAL INSULIN-LIKE GROWTH FACTORS MARKET – ANALYSIS & FORECAST, BY END USER
   1. Hospitals
   2. Medical Centers

INSULIN-LIKE GROWTH FACTORS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-9034

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Dental Apex Locator Market by Product Type (Equipment, Accessories), End User (Hospitals, Dental Clinics) – Global Outlook & Forecast 2021-2031

Specific Protein Testing Market by Application (Cardiovascular diseases, Immunity), Product Type (Cystatin C, Apolipoprotein E), Sample Type (Blood, Urine) End User (Hospital, Biotechnology Companies) – Global Outlook & Forecast 2023-2031

Dental Anesthetic Market by Type (Local, General), End User (Hospitals, Dental Clinics) – Global Outlook & Forecast 2021-2031

In Vitro Diagnostic Substrate Market by Substrate Type (TMB Substrate, PNPP (p-Nitrophenyl Phosphate, Disodium Salt) Substrate), Test Type (IHC Test, ELISA Test), Application (Oncology, Nephrology), End User (Hospital Laboratories, Diagnostic Centers) – Global Outlook & Forecast 2023-2031

Propranolol Drugs Market by Route of Administration (Oral Administration), Application (Hypertension, Angina), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.